Table 1. The characteristic of thirteen selected peaks.
| Peptides peaks(m/z) | P value | Cancer group | Control group |
|---|---|---|---|
| 1053.1 | <0.0001 | 1679.8±772.5 | 839.0±564.7 |
| 1490.9 | <0.0001 | 639.4±205.7 | 418.9±187.9 |
| 1085 | 0.0430 | 789.4±356.7 | 623.1±263.3 |
| 1258.8 | <0.0001 | 560.5±273.8 | 271.6±171.2 |
| 1280.1 | 0.0010 | 1625.4±666.8 | 1075.3±646.1 |
| 1069.1 | 0.0080 | 2196.6±856.3 | 1588.5±983.0 |
| 1306.1 | 0.0010 | 637.2±503.1 | 1083.9±620.7 |
| 1719.5 | <0.0001 | 343.2±390.7 | 1023.7±700.8 |
| 1736.6 | 0.0010 | 352.3±439.5 | 737.1±462.4 |
| 1833.4 | <0.000 | 230.7±315.4 | 742.0±508.0 |
| 2756.6 | <0.000 | 269.5±401.6 | 832.6±662.1 |
| 1097.8 | 0.2720 | 616.3±248.2 | 550.0±252.2 |
| 1296.2 | 0.7530 | 663.9±293.2 | 689.5±378.0 |
The peak area of every peak in two groups was presented as mean ± SD. P value was calculated by t-test (normally distributed continuous data) or Mann-Whiney U-test (non-normally distributed continuous data). P<0.05 was considered as statistically significant difference.